Freestone Capital Holdings’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-15,765
| Closed | -$789K | – | 431 |
|
|
2022
Q2 | $789K | Sell |
15,765
-73,653
| -82% | -$3.91M | 0.03% | 228 |
|
|
2022
Q1 | $4.59M | Buy |
89,418
+14,129
| +19% | +$730K | 0.18% | 116 |
|
|
2021
Q4 | $3.77M | Buy |
75,289
+1,319
| +2% | +$65.2K | 0.16% | 132 |
|
|
2021
Q3 | $3.57M | Sell |
73,970
-249
| -0.3% | -$12.7K | 0.18% | 130 |
|
|
2021
Q2 | $3.91M | Buy |
74,219
+2,397
| +3% | +$125K | 0.2% | 125 |
|
|
2021
Q1 | $3.55M | Buy |
71,822
+2,212
| +3% | +$106K | 0.19% | 128 |
|
|
2020
Q4 | $3.38M | Sell |
69,610
-2,718
| -4% | -$134K | 0.2% | 126 |
|
|
2020
Q3 | $3.63M | Buy |
72,328
+4,837
| +7% | +$249K | 0.24% | 92 |
|
|
2020
Q2 | $3.44K | Buy |
67,491
+8,424
| +14% | +$409K | 0.04% | 108 |
|
|
2020
Q1 | $2.58K | Buy |
59,067
+24,599
| +71% | +$1.18M | 0.06% | 115 |
|
|
2019
Q4 | $1.73K | Buy |
34,468
+6,935
| +25% | +$325K | 0.04% | 188 |
|
|
2019
Q3 | $1.28K | Buy |
27,533
+7,766
| +39% | +$335K | 0.03% | 229 |
|
|
2019
Q2 | $855 | Buy |
19,767
+5,440
| +38% | +$231K | 0.02% | 249 |
|
|
2019
Q1 | $634K | Sell |
14,327
-94,324
| -87% | -$4.04M | 0.04% | 262 |
|
|
2018
Q4 | $4.72M | Sell |
108,651
-124,755
| -53% | -$5.5M | 0.32% | 92 |
|
|
2018
Q3 | $10.4M | Sell |
233,406
-8,845
| -4% | -$378K | 0.07% | 49 |
|
|
2018
Q2 | $9.69M | Buy |
242,251
+9,229
| +4% | +$363K | 0.06% | 56 |
|
|
2018
Q1 | $9.34M | Buy |
233,022
+36,393
| +19% | +$1.51M | 0.54% | 52 |
|
|
2017
Q4 | $8.46M | Buy |
196,629
+102,217
| +108% | +$4.71M | 0.59% | 49 |
|
|
2017
Q3 | $4.7M | Buy |
94,412
+10,720
| +13% | +$519K | 0.33% | 92 |
|
|
2017
Q2 | $4.01M | Buy |
83,692
+8,615
| +11% | +$412K | 0.31% | 85 |
|
|
2017
Q1 | $3.4M | Buy |
75,077
+8,741
| +13% | +$371K | 0.26% | 92 |
|
|
2016
Q4 | $2.68M | Buy |
66,336
+7,051
| +12% | +$278K | 0.23% | 111 |
|
|
2016
Q3 | $2.26M | Buy |
59,285
+4,919
| +9% | +$197K | 0.21% | 118 |
|
|
2016
Q2 | $2.27M | Buy |
54,366
+10,284
| +23% | +$422K | 0.22% | 92 |
|
|
2016
Q1 | $1.77M | Buy |
44,082
+4,889
| +12% | +$196K | 0.19% | 103 |
|
|
2015
Q4 | $1.67M | Buy |
+39,193
| New | +$1.8M | 0.17% | 89 |
|
|
2014
Q3 | – | Sell |
-25,191
| Closed | -$1.34M | – | 173 |
|
|
2014
Q2 | $1.34M | Sell |
25,191
-1,809
| -7% | -$96K | 0.21% | 81 |
|
|
2014
Q1 | $1.41M | Sell |
27,000
-8,533
| -24% | -$432K | 0.25% | 65 |
|
|
2013
Q4 | $1.91M | Sell |
35,533
-418
| -1% | -$21.6K | 0.34% | 47 |
|
|
2013
Q3 | $1.82M | Sell |
35,951
-25,848
| -42% | -$1.32M | 0.32% | 54 |
|
|
2013
Q2 | $3.18M | Buy |
+61,799
| New | +$3.29M | 0.65% | 33 |
|
Other funds holding SNY
CCM
Freestone Capital Holdings's SNY Position: Q3 2022 in Review
Freestone Capital Holdings sold out of Sanofi (SNY) in Q3 2022, closing a stake of 15,765 shares — an estimated $789K sold.
Freestone Capital Holdings first reported a position in SNY in Q2 2013 and held it in 32 quarters. The position peaked at $10.4M in Q3 2018. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.
- Freestone Capital Holdings reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
- Freestone Capital Holdings sold 15,765 Sanofi shares in Q3 2022, an estimated $789K.
- Freestone Capital Holdings first reported a position in Sanofi in Q2 2013 and held it in 32 quarters.
- Freestone Capital Holdings's Sanofi position peaked at $10.4M in Q3 2018.
- 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.
Based on Freestone Capital Holdings's 13F filing for Q3 2022, filed 9 Nov 2022.